Kinnate Biopharma Inc. Debt to Equity Ratio 2021-2023 | KNTE
Current and historical debt to equity ratio values for Kinnate Biopharma Inc. (KNTE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Kinnate Biopharma Inc. debt/equity for the three months ending December 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.01B | $0.16B | 0.09 |
| 2023-09-30 | $0.02B | $0.17B | 0.11 |
| 2023-06-30 | $0.02B | $0.20B | 0.09 |
| 2023-03-31 | $0.02B | $0.22B | 0.10 |
| 2022-12-31 | $0.06B | $0.22B | 0.25 |
| 2022-09-30 | $0.05B | $0.25B | 0.22 |
| 2022-06-30 | $0.05B | $0.27B | 0.18 |
| 2022-03-31 | $0.05B | $0.30B | 0.18 |
| 2021-12-31 | $0.05B | $0.32B | 0.15 |
| 2021-09-30 | $0.05B | $0.34B | 0.13 |
| 2021-06-30 | $0.04B | $0.36B | 0.12 |
| 2021-03-31 | $0.01B | $0.38B | 0.02 |
| 2020-12-31 | $0.01B | $0.39B | 0.02 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
